Santa Barbara, CA, April 8, 2008–Wiley Systems, Inc. today announced its participation in the Spring 2008 ACAM Conference in Orlando, Florida from April 9 to 13, 2008, at Booth 103. T.S. Wiley, the author and founder of the Wiley Protocol (www.thewileyprotocol.com) will be introducing the new Wiley Protocol® branded products based on bio-mimetic hormone restoration therapy (BHRT), currently termed bio-identical hormone replacement therapy. Other leading experts in the field of complementary, alternative and integrative medicine will convene at the ACAM conference to hear about the latest research, alternative methods of treatment, and new advances in patient care.

Mounting evidence on the Wiley Protocol indicates that it may have been the rhythm that was always missing in other regimens. To supplement its original focus on female estrogen and progesterone hormones, Wiley Systems has released five new original Wiley Protocol bio-mimetic creams that replicate ancillary hormone rhythms including two hormone creams as part of a male hormone therapy program to help optimize men’s health.  

The following five rhythmic dosing schedules have been introduced to medical practitioners and pharmacists: Wiley Protocol for Men™, bio-mimetic DHEA and testosterone restoration; Wiley Protocol Thyroid™, bio-mimetic thyroid hormone restoration; Wiley Protocol Testosterone ™ for Women, bio-mimetic testosterone restoration; and Wiley Protocol Face Crème, which promotes a more youthful appearance by filling in fine lines.

After 12 years of research, Wiley developed a novel method of hormone restoration therapy (HRT) called the Wiley Protocol®. The Wiley Protocol allows women a more accurate form of replacement for lost endocrine function. Thousands of women love it. Mounting evidence on the Wiley Protocol indicates that it may have been the rhythm that was always missing in other regimens. The components of the Wiley Protocol and their amounts vary throughout the 28 day cycle to mimic the hormone levels of youth. The Wiley Protocol is the only “bio-identical hormone replacement therapy” (BHRT) that features plant derived hormones in a bio-mimetic way, or that has ever been developed under the scrutiny of a practicing oncologist.

Wiley is a medical theorist in the fields of Darwinian medicine and Environmental Endocrinology. She is a noted writer and researcher on the use of hormones, particularly in menopausal women. As an expert in chronobiology and circadian rhythmicity, as they pertain to endocrinology, Wiley’s CME accredited seminars are attended by physicians from all over the world. Wiley is the author of “Sex, Lies & Menopause,” Harper Collins, 2005 and “Lights Out: Sleep, Sugar and Survival,” Simon & Schuster, Inc., 2000.

About American College for Advancement in Medicine (ACAM)
The American College for Advancement in Medicine (ACAM) is a not-for-profit medical society dedicated to educating physicians and other health care professionals on the latest findings and emerging procedures in preventive/nutritional medicine. ACAM's goals are to improve skills, knowledge and diagnostic procedures as they relate to complementary and alternative medicine; to support research; and to develop awareness of alternative methods of medical treatment.

Celebrating more than a quarter century of service, ACAM represents more than 1,000 physicians in 30 countries. ACAM is the largest and oldest organization of its kind in the world dedicated exclusively to serving the educational needs of the health professions. Contact Drew McGray, Corporate Communications, 949-309-3525, The American College for Advancement in Medicine (ACAM).

About Wiley Systems, Inc. and the Wiley Protocol
Wiley Systems, Inc. was founded in 2005 in Santa Barbara, California by T.S. Wiley, who is the developer of the Wiley Protocol, a trademarked patent pending delivery system consisting of bio-mimetic, estradiol and progesterone (Bio-Mimetic Hormone Restoration Therapy) also known as bio-identical hormone replacement therapy. Wiley Systems began as a project to unite doctors and pharmacists in a common goal to standardize bio-identical hormones for academic research. Wiley Systems offers the packaging to color code and accurately titrate dosing for the Wiley Protocol to pharmacies who join the project for future NIH study.

The Wiley Protocol is only available at compounding pharmacies that have contractually agreed to the standardized methods, materials, packaging and recommended pricing. In exchange, Wiley Systems provides intellectual property and sells 28WP logo-bearing packaging consisting of bags and syringes in the branded colors of purple and green. The Wiley Protocol name assures customers that they are receiving authentic Wiley Protocol dosing rhythms based on original research.

*This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of MEC and the Wiley Protocol. MEC is accredited by the ACCME to provide continuing medical education for physicians.

Contact:
Kristin Gabriel, Director of Marketing
O: 323.650.2838; C: 213.840.6978
E: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

Wiley Systems
P.O. Box 50734
O: 805.565.7508; F: 805 456-3939
www.thewileyprotocol.com